LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $983,707 | +161.5% | 16,417 | +214.6% | 0.00% | – |
| Q2 2023 | $376,218 | -24.0% | 5,218 | -22.4% | 0.00% | – |
| Q1 2023 | $494,838 | -58.0% | 6,727 | -50.8% | 0.00% | -100.0% |
| Q3 2022 | $1,177,000 | -4.9% | 13,665 | +24.2% | 0.00% | – |
| Q1 2022 | $1,237,000 | -84.3% | 11,000 | -78.4% | 0.00% | -100.0% |
| Q4 2021 | $7,862,000 | +13.8% | 50,896 | +2.7% | 0.00% | +50.0% |
| Q3 2021 | $6,908,000 | -11.1% | 49,582 | -16.3% | 0.00% | -33.3% |
| Q2 2021 | $7,772,000 | -87.5% | 59,241 | -85.5% | 0.00% | -90.3% |
| Q1 2021 | $62,125,000 | +1344.8% | 407,512 | +842.5% | 0.03% | +1450.0% |
| Q4 2020 | $4,300,000 | -50.7% | 43,238 | -52.8% | 0.00% | -66.7% |
| Q3 2020 | $8,723,000 | -64.9% | 91,515 | -58.8% | 0.01% | -66.7% |
| Q2 2020 | $24,829,000 | +188.4% | 221,982 | +87.5% | 0.02% | +100.0% |
| Q1 2020 | $8,610,000 | +146.0% | 118,400 | +252.8% | 0.01% | +125.0% |
| Q4 2019 | $3,500,000 | +651.1% | 33,556 | +616.5% | 0.00% | +300.0% |
| Q3 2019 | $466,000 | -49.1% | 4,683 | -41.7% | 0.00% | -50.0% |
| Q2 2019 | $916,000 | -23.0% | 8,027 | -15.2% | 0.00% | 0.0% |
| Q1 2019 | $1,190,000 | -68.5% | 9,462 | -66.0% | 0.00% | -75.0% |
| Q4 2018 | $3,773,000 | +96.1% | 27,810 | +296.7% | 0.01% | +100.0% |
| Q3 2018 | $1,924,000 | +422.8% | 7,010 | +294.5% | 0.00% | +300.0% |
| Q2 2018 | $368,000 | +34.3% | 1,777 | +7.1% | 0.00% | 0.0% |
| Q1 2018 | $274,000 | +33.7% | 1,659 | -1.7% | 0.00% | 0.0% |
| Q2 2017 | $205,000 | -97.4% | 1,688 | -97.8% | 0.00% | -97.1% |
| Q1 2017 | $7,989,000 | +1766.6% | 75,482 | +1787.0% | 0.04% | +1650.0% |
| Q1 2016 | $428,000 | -69.0% | 4,000 | -70.7% | 0.00% | -77.8% |
| Q2 2015 | $1,379,000 | +408.9% | 13,660 | +167.8% | 0.01% | +350.0% |
| Q4 2014 | $271,000 | -47.8% | 5,100 | -38.8% | 0.00% | -71.4% |
| Q2 2014 | $519,000 | – | 8,327 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |